Biotherapeutics Cell Line Development and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Biotherapeutics Cell Line Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biotherapeutics Cell Line Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biotherapeutics Cell Line Development Overall Market Size
2.1 Global Biotherapeutics Cell Line Development Market Size: 2022 VS 2030
2.2 Global Biotherapeutics Cell Line Development Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biotherapeutics Cell Line Development Players in Global Market
3.2 Top Global Biotherapeutics Cell Line Development Companies Ranked by Revenue
3.3 Global Biotherapeutics Cell Line Development Revenue by Companies
3.4 Top 3 and Top 5 Biotherapeutics Cell Line Development Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biotherapeutics Cell Line Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biotherapeutics Cell Line Development Players in Global Market
3.6.1 List of Global Tier 1 Biotherapeutics Cell Line Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Biotherapeutics Cell Line Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biotherapeutics Cell Line Development Market Size Markets, 2022 & 2030
4.1.2 Transfection & Selection
4.1.3 Single Cell Cloning
4.2 By Type - Global Biotherapeutics Cell Line Development Revenue & Forecasts
4.2.1 By Type - Global Biotherapeutics Cell Line Development Revenue, 2018-2023
4.2.2 By Type - Global Biotherapeutics Cell Line Development Revenue, 2024-2030
4.2.3 By Type - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biotherapeutics Cell Line Development Market Size, 2022 & 2030
5.1.2 In-house
5.1.3 Outsource
5.1.4 Hybrid
5.1.5 Do-It-Yourself (DIY)
5.2 By Application - Global Biotherapeutics Cell Line Development Revenue & Forecasts
5.2.1 By Application - Global Biotherapeutics Cell Line Development Revenue, 2018-2023
5.2.2 By Application - Global Biotherapeutics Cell Line Development Revenue, 2024-2030
5.2.3 By Application - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Biotherapeutics Cell Line Development Market Size, 2022 & 2030
6.2 By Region - Global Biotherapeutics Cell Line Development Revenue & Forecasts
6.2.1 By Region - Global Biotherapeutics Cell Line Development Revenue, 2018-2023
6.2.2 By Region - Global Biotherapeutics Cell Line Development Revenue, 2024-2030
6.2.3 By Region - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Biotherapeutics Cell Line Development Revenue, 2018-2030
6.3.2 US Biotherapeutics Cell Line Development Market Size, 2018-2030
6.3.3 Canada Biotherapeutics Cell Line Development Market Size, 2018-2030
6.3.4 Mexico Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Biotherapeutics Cell Line Development Revenue, 2018-2030
6.4.2 Germany Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.3 France Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.4 U.K. Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.5 Italy Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.6 Russia Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.7 Nordic Countries Biotherapeutics Cell Line Development Market Size, 2018-2030
6.4.8 Benelux Biotherapeutics Cell Line Development Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Biotherapeutics Cell Line Development Revenue, 2018-2030
6.5.2 China Biotherapeutics Cell Line Development Market Size, 2018-2030
6.5.3 Japan Biotherapeutics Cell Line Development Market Size, 2018-2030
6.5.4 South Korea Biotherapeutics Cell Line Development Market Size, 2018-2030
6.5.5 Southeast Asia Biotherapeutics Cell Line Development Market Size, 2018-2030
6.5.6 India Biotherapeutics Cell Line Development Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Biotherapeutics Cell Line Development Revenue, 2018-2030
6.6.2 Brazil Biotherapeutics Cell Line Development Market Size, 2018-2030
6.6.3 Argentina Biotherapeutics Cell Line Development Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biotherapeutics Cell Line Development Revenue, 2018-2030
6.7.2 Turkey Biotherapeutics Cell Line Development Market Size, 2018-2030
6.7.3 Israel Biotherapeutics Cell Line Development Market Size, 2018-2030
6.7.4 Saudi Arabia Biotherapeutics Cell Line Development Market Size, 2018-2030
6.7.5 UAE Biotherapeutics Cell Line Development Market Size, 2018-2030
7 Biotherapeutics Cell Line Development Companies Profiles
7.1 Becton Dickinson & Company
7.1.1 Becton Dickinson & Company Company Summary
7.1.2 Becton Dickinson & Company Business Overview
7.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Major Product Offerings
7.1.4 Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.1.5 Becton Dickinson & Company Key News & Latest Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Company Summary
7.2.2 Beckman Coulter Business Overview
7.2.3 Beckman Coulter Biotherapeutics Cell Line Development Major Product Offerings
7.2.4 Beckman Coulter Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.2.5 Beckman Coulter Key News & Latest Developments
7.3 Boehringer Ingelheim Group
7.3.1 Boehringer Ingelheim Group Company Summary
7.3.2 Boehringer Ingelheim Group Business Overview
7.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Major Product Offerings
7.3.4 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Group Key News & Latest Developments
7.4 Catalent Inc.
7.4.1 Catalent Inc. Company Summary
7.4.2 Catalent Inc. Business Overview
7.4.3 Catalent Inc. Biotherapeutics Cell Line Development Major Product Offerings
7.4.4 Catalent Inc. Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.4.5 Catalent Inc. Key News & Latest Developments
7.5 CMC Biologics A/S
7.5.1 CMC Biologics A/S Company Summary
7.5.2 CMC Biologics A/S Business Overview
7.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Major Product Offerings
7.5.4 CMC Biologics A/S Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.5.5 CMC Biologics A/S Key News & Latest Developments
7.6 Lonza Group Ltd.
7.6.1 Lonza Group Ltd. Company Summary
7.6.2 Lonza Group Ltd. Business Overview
7.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Major Product Offerings
7.6.4 Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.6.5 Lonza Group Ltd. Key News & Latest Developments
7.7 EMD Millipore
7.7.1 EMD Millipore Company Summary
7.7.2 EMD Millipore Business Overview
7.7.3 EMD Millipore Biotherapeutics Cell Line Development Major Product Offerings
7.7.4 EMD Millipore Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.7.5 EMD Millipore Key News & Latest Developments
7.8 Partec (Sysmex Corporation)
7.8.1 Partec (Sysmex Corporation) Company Summary
7.8.2 Partec (Sysmex Corporation) Business Overview
7.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Major Product Offerings
7.8.4 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.8.5 Partec (Sysmex Corporation) Key News & Latest Developments
7.9 ProBioGen AG
7.9.1 ProBioGen AG Company Summary
7.9.2 ProBioGen AG Business Overview
7.9.3 ProBioGen AG Biotherapeutics Cell Line Development Major Product Offerings
7.9.4 ProBioGen AG Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.9.5 ProBioGen AG Key News & Latest Developments
7.10 Selexis SA
7.10.1 Selexis SA Company Summary
7.10.2 Selexis SA Business Overview
7.10.3 Selexis SA Biotherapeutics Cell Line Development Major Product Offerings
7.10.4 Selexis SA Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.10.5 Selexis SA Key News & Latest Developments
7.11 Sigma-Aldrich Co. LLC.
7.11.1 Sigma-Aldrich Co. LLC. Company Summary
7.11.2 Sigma-Aldrich Co. LLC. Business Overview
7.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Major Product Offerings
7.11.4 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.11.5 Sigma-Aldrich Co. LLC. Key News & Latest Developments
7.12 Sony Biotechnology Inc.
7.12.1 Sony Biotechnology Inc. Company Summary
7.12.2 Sony Biotechnology Inc. Business Overview
7.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Major Product Offerings
7.12.4 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.12.5 Sony Biotechnology Inc. Key News & Latest Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Company Summary
7.13.2 Thermo Fisher Scientific Inc. Business Overview
7.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Major Product Offerings
7.13.4 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue in Global Market (2018-2023)
7.13.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biotherapeutics Cell Line Development Market Opportunities & Trends in Global Market
Table 2. Biotherapeutics Cell Line Development Market Drivers in Global Market
Table 3. Biotherapeutics Cell Line Development Market Restraints in Global Market
Table 4. Key Players of Biotherapeutics Cell Line Development in Global Market
Table 5. Top Biotherapeutics Cell Line Development Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biotherapeutics Cell Line Development Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biotherapeutics Cell Line Development Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biotherapeutics Cell Line Development Product Type
Table 9. List of Global Tier 1 Biotherapeutics Cell Line Development Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biotherapeutics Cell Line Development Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Biotherapeutics Cell Line Development Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biotherapeutics Cell Line Development Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Biotherapeutics Cell Line Development Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biotherapeutics Cell Line Development Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Biotherapeutics Cell Line Development Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biotherapeutics Cell Line Development Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2024-2030
Table 30. Becton Dickinson & Company Company Summary
Table 31. Becton Dickinson & Company Biotherapeutics Cell Line Development Product Offerings
Table 32. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 33. Becton Dickinson & Company Key News & Latest Developments
Table 34. Beckman Coulter Company Summary
Table 35. Beckman Coulter Biotherapeutics Cell Line Development Product Offerings
Table 36. Beckman Coulter Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 37. Beckman Coulter Key News & Latest Developments
Table 38. Boehringer Ingelheim Group Company Summary
Table 39. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product Offerings
Table 40. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Group Key News & Latest Developments
Table 42. Catalent Inc. Company Summary
Table 43. Catalent Inc. Biotherapeutics Cell Line Development Product Offerings
Table 44. Catalent Inc. Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 45. Catalent Inc. Key News & Latest Developments
Table 46. CMC Biologics A/S Company Summary
Table 47. CMC Biologics A/S Biotherapeutics Cell Line Development Product Offerings
Table 48. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 49. CMC Biologics A/S Key News & Latest Developments
Table 50. Lonza Group Ltd. Company Summary
Table 51. Lonza Group Ltd. Biotherapeutics Cell Line Development Product Offerings
Table 52. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 53. Lonza Group Ltd. Key News & Latest Developments
Table 54. EMD Millipore Company Summary
Table 55. EMD Millipore Biotherapeutics Cell Line Development Product Offerings
Table 56. EMD Millipore Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 57. EMD Millipore Key News & Latest Developments
Table 58. Partec (Sysmex Corporation) Company Summary
Table 59. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product Offerings
Table 60. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 61. Partec (Sysmex Corporation) Key News & Latest Developments
Table 62. ProBioGen AG Company Summary
Table 63. ProBioGen AG Biotherapeutics Cell Line Development Product Offerings
Table 64. ProBioGen AG Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 65. ProBioGen AG Key News & Latest Developments
Table 66. Selexis SA Company Summary
Table 67. Selexis SA Biotherapeutics Cell Line Development Product Offerings
Table 68. Selexis SA Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 69. Selexis SA Key News & Latest Developments
Table 70. Sigma-Aldrich Co. LLC. Company Summary
Table 71. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product Offerings
Table 72. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 73. Sigma-Aldrich Co. LLC. Key News & Latest Developments
Table 74. Sony Biotechnology Inc. Company Summary
Table 75. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product Offerings
Table 76. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 77. Sony Biotechnology Inc. Key News & Latest Developments
Table 78. Thermo Fisher Scientific Inc. Company Summary
Table 79. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product Offerings
Table 80. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue (US$, Mn) & (2018-2023)
Table 81. Thermo Fisher Scientific Inc. Key News & Latest Developments
List of Figures
Figure 1. Biotherapeutics Cell Line Development Segment by Type in 2022
Figure 2. Biotherapeutics Cell Line Development Segment by Application in 2022
Figure 3. Global Biotherapeutics Cell Line Development Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biotherapeutics Cell Line Development Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Biotherapeutics Cell Line Development Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2022
Figure 8. By Type - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 9. By Application - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 10. By Type - Global Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 12. By Application - Global Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 14. By Region - Global Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 15. By Country - North America Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 16. US Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 20. Germany Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 21. France Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 28. China Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 32. India Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 34. Brazil Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Biotherapeutics Cell Line Development Revenue Market Share, 2018-2030
Figure 37. Turkey Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Biotherapeutics Cell Line Development Revenue, (US$, Mn), 2018-2030
Figure 41. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Beckman Coulter Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Catalent Inc. Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. EMD Millipore Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ProBioGen AG Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Selexis SA Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
